Camrelizumab Chemical Properties

storage temp. 

4°C, Do not freeze, Protect from light.

form 

Solid

color 

White to light yellow

Camrelizumab Usage And Synthesis

Uses

Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab?binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as?anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al[1][2].

in vivo

References

[1] Kuimin Mei, et al. Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial. J Immunother Cancer. 2021 Mar;9(3):e002191. DOI:10.1136/jitc-2020-002191
[2] Jason D Lickliter, et al.A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia. Drug Des Devel Ther DOI:10.2147/DDDT.S243787
[3] Caicun Zho, et al.Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial. Lancet Respir Med.?2021 Mar;9(3):305-314. DOI:10.1016/S2213-2600(20)30365-9

Camrelizumab(1798286-48-2)Related Product Information

• ticilimumab tremelimumab
• Tislelizumab
• Talizumab
• Oleclumab
• Zagotenemab
• Balstilimab
• Sifalimumab
• Ficlatuzumab
• Elotuzumab
• Netakimab